Showing results (2101-2110 of 2,501) with videos related to

Sort By:
Pageof 251
Scientific Reports|October 27, 2022
Gauging the skin resident Leishmania parasites through a loop mediated isothermal amplification (LAMP) assay in post-kala-azar dermal leishmaniasisPrakash Ghosh, Rajashree Chowdhury, Shomik Maruf, et al.
NPJ Primary Care Respiratory Medicine|December 13, 2022
Accuracy and economic evaluation of screening tests for undiagnosed COPD among hypertensive individuals in BrazilS M Martins, A P Dickens, W Salibe-Filho, et al.
Communications Medicine|February 6, 2026
Machine learning to infer neurocognitive testing scores among adolescents and young adults with congenital heart diseaseMohammad Arafat Hussain, Sheng He, Heather R Adams, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Targeting melanosome pH is an effective method for the treatment of oculocutaneous albinismSamuel J Grondin, Daniela St Pierre, David J Green, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2008
Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivativesRoger J Gillespie, David R Adams, David Bebbington, et al.
Bone Marrow Transplantation|February 10, 2004
Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphomaG L Phillips, B R Meisenberg, D E Reece, et al.
Pediatric Neurology|March 25, 2017
Management Strategies for CLN2 DiseaseRuth E Williams, Heather R Adams, Martin Blohm, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Ampyrone (4-Aminoantipyrine) is a Direct Agonist of Human Tyrosinase and Potential Therapeutic for Oculocutaneous Albinism and Disorders of HypopigmentationMonika B Dolinska, Yuhong Wang, Nathan P Coussens, et al.
Palliative Medicine Reports|October 27, 2025
Hospital and Temporal Variations in Limitations of Care Among Hospitalized Patients with COVID-19: A VIRUS Registry Retrospective Cohort StudyNathan Mesfin, Nitesh Kumar Jain, Anwar Khedr, et al.
JCI Insight|June 18, 2026
Ampyrone is a direct agonist of human tyrosinase and a potential therapeutic for hypopigmentation disordersMonika B Dolinska, Yuhong A Wang, Nathan P Coussens, et al.
Pageof 251